Primary Cutaneous Marginal Zone Lymphoma With Leptomeningeal Involvement and a Durable Response to Rituximab

JAAD Case Reports - United States
doi 10.1016/j.jdcr.2017.02.024
Full Text
Abstract

Available in full text

Categories
Dermatology
Date
Authors
Publisher

Elsevier BV

Related search

Primary Splenic Marginal Zone Lymphoma: A Case Report

Pathology
Forensic MedicinePathology
2016English

Idelalisib and Rituximab in 17p Deletion–Positive Splenic Marginal Zone Lymphoma

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2018English

Image Gallery: Metachronic Occurrence of Primary Cutaneous Marginal Zone B-Cell Lymphoma and Primary Cutaneous Rosai-Dorfman Disease in the Same Patient

British Journal of Dermatology
DermatologyMedicine
2017English

Rituximab Alone (R) Versus Rituximab Plus Bendamustine (Br) for Splenic (Smzl) and Nodal Marginal Zone Lymphoma (Nmzl)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Splenic Marginal Zone Lymphoma

2020English

Primary Leptomeningeal Lymphoma: International Primary CNS Lymphoma Collaborative Group Report

Neurology
Neurology
2013English

Post Hoc Analyses of Patients With Relapsed/Refractory Marginal Zone Lymphoma Who Received Lenalidomide Plus Rituximab (R2 ) vs Rituximab/Placebo (Augment)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Marginal Zone B-Cell Lymphoma

English

A Case of Splenic Marginal Zone Lymphoma

Japanese Journal of Gastroenterological Surgery
SurgeryGastroenterology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy